Marked and rapid reductions in both pericarditis pain and inflammation maintained throughout the 26-week study Episodes of pericarditis per year substantially reduced MAvERIC-Pilot results support advancing CardiolRx into the Phase II/III MAVERIC-2and the Phase III MAVERIC-3 clinical trials Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (‘Cardiol’ or
U.S. stock futures dropped early Friday as the postelection rally showed signs of faltering and the Federal Reserve indicated a cautious stance on further interest rate cuts. Dow Jones Industrial Average futures fell 156 points, or 0.36%, while S&P 500 and Nasdaq 100 futures declined
In the fast-paced world of cryptocurrency trading, having a strategic edge is essential for investors aiming to navigate the volatile markets. PamBoRich, a rising star in the financial sector, is known for its innovative approach to automated trading solutions. With a reputation for cutting-edge technology
Attorneys for X Corp., the firm established by Elon Musk to take over Twitter, filed a notice of appearance on Thursday in the bankruptcy case of Alex Jones and his Infowars platform. The new owners of satirical news site The Onion had been declared the successful
As the secular bull market takes a short-term pause, now is the time to research tremendous opportunities that lie ahead. I’ve looked at more than a thousand charts and wanted to point out 3 in particular that I see heading much, much higher as
U.S. stock futures dropped early Friday as the postelection rally showed signs of faltering and the Federal Reserve indicated a cautious stance on further interest rate cuts. Dow Jones Industrial Average futures fell 156 points, or 0.36%, while S&P 500 and Nasdaq 100 futures declined
As the cybersecurity landscape continues to evolve with increasing digital threats, Zscaler, Inc. (ZS) stands out as a new opportunity after lagging for most of 2024. Recent chart setups in Zscaler stock suggest ZS may be gearing up for a significant bullish trend. In this analysis,
There’s no denying the strength that the mega-cap growth names have exerted on the equity markets in 2024. With their outsized weight in the major equity averages, and their strong performance into November 2024, the Magnificent 7 stocks in many ways reflect the investor optimism that
(This is an excerpt from the subscriber-only DP Weekly Wrap for Friday) On Friday, the Biotechnology ETF (IBB) 20-day EMA crossed down through the 50-day EMA (Dark Cross) and above the 200-day EMA, generating an IT Trend Model NEUTRAL Signal. IBB recently switched to a BUY
“The economy is not sending any signals that we need to be in a hurry to lower rates.” These words from Chairman Powell impacted the stock market much more than this week’s inflation data. The stock market started selling off on Thursday afternoon and continued to